NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD - Announcements

5.56%

17.0¢

Market Cap $56.53M

Healthcare Biotechnology

NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is... NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's product portfolio includes EmtinB, a therapeutic peptide initially targeting glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn and EmtinBn). EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury. Its StemSmart is a global patented technology engaged in manufacturing cell products. The use of its proprietary StemSmart technology in a special access program for fistulising Crohn’s disease.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

NSB	Change of Director's Interest Notice		18/05/21	215.07KB	Share
NSB	Update on Pivotal Ocular Safety Studies	PRICE SENSITIVE	05/05/21	618.43KB	Share
NSB	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/21	280.13KB	Share
NSB	Manufacturing Update	PRICE SENSITIVE	28/04/21	81.69KB	Share
NSB	Key Executive Appointments to Support Clinical Studies	PRICE SENSITIVE	31/03/21	109.58KB	Share
NSB	Change in substantial holding		11/03/21	201.99KB	Share
NSB	Appendix 2A		11/03/21	291.78KB	Share
NSB	Strong Investor Support for Exercise of Listed Options		11/03/21	98.29KB	Share
NSB	Appendix 2A		08/03/21	287.51KB	Share
NSB	Appendix 2A		03/03/21	290.5KB	Share
NSB	Change of Director's Interest Notice		03/03/21	214.59KB	Share
NSB	Appendix 2A		26/02/21	290.59KB	Share
NSB	Change of Director's Interest Notice		26/02/21	218.46KB	Share
NSB	Appendix 2A		24/02/21	290.62KB	Share
NSB	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/21	458.12KB	Share
NSB	Change of Director's Interest Notice		18/02/21	215.6KB	Share
NSB	Appendix 2A		18/02/21	290.56KB	Share
NSB	Appendix 2A		16/02/21	290.56KB	Share
NSB	Appendix 2A		12/02/21	289.41KB	Share
NSB	Change in substantial holding		05/02/21	224.12KB	Share
NSB	Appendix 2A		05/02/21	289.22KB	Share
NSB	Appendix 2A		29/01/21	290.54KB	Share
NSB	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/21	298.77KB	Share
NSB	Last Date of Quotation of Listed Options		27/01/21	99.57KB	Share
NSB	Expiry of Listed Options		25/01/21	525.54KB	Share
NSB	Appendix 2A		22/01/21	290.35KB	Share
NSB	Appendix 2A		15/01/21	290.36KB	Share
NSB	Appendix 3Y		15/01/21	179.9KB	Share
NSB	Appendix 3Y		15/01/21	179.25KB	Share
NSB	Appendix 3Y		15/01/21	177.2KB	Share
NSB	Appendix 3Y		15/01/21	180.74KB	Share
NSB	Appendix 3G		15/01/21	270.37KB	Share
NSB	Appendix 2A		08/01/21	290.09KB	Share
NSB	Appendix 2A		18/12/20	289.98KB	Share
NSB	Results of Meeting		07/12/20	287.96KB	Share
NSB	Chairman's Address to Shareholders		07/12/20	1.82MB	Share
NSB	Appendix 2A		03/12/20	289.95KB	Share
NSB	Corporate Governance Statement		27/11/20	219.98KB	Share
NSB	Appendix 4G		25/11/20	256.26KB	Share
NSB	NSB to investigate treatment for post-COVID Fibrosis	PRICE SENSITIVE	20/11/20	219.65KB	Share
NSB	Trading Halt	PRICE SENSITIVE	19/11/20	264.08KB	Share
NSB	Cleansing Notice		16/11/20	121.71KB	Share
NSB	Appendix 2A		16/11/20	289.45KB	Share
NSB	Completion of Strategic Placement		16/11/20	103.02KB	Share
NSB	Cleansing Notice		11/11/20	122.28KB	Share
NSB	Terms of Lead Manager Options		11/11/20	114.97KB	Share
NSB	Proposed issue of Securities - NSB		11/11/20	28.11KB	Share
NSB	Strategic Placement to AlphaSwiss Partners	PRICE SENSITIVE	11/11/20	130.2KB	Share
NSB	Trading Halt	PRICE SENSITIVE	09/11/20	601.76KB	Share
NSB	Letter to Shareholders - Notice of Meeting/Proxy form		30/10/20	93.38KB	Share
NSB	Notice of Annual General Meeting/Proxy Form		30/10/20	988.62KB	Share
NSB	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/20	321.92KB	Share
NSB	AusBiotech Invest 2020 Conference Presentation		28/10/20	1.86MB	Share
NSB	Appendix 2A		13/10/20	282.98KB	Share
NSB	BIO Investor Forum Presentation		13/10/20	1.64MB	Share
NSB	Appendix 2A		30/09/20	291.46KB	Share
NSB	Details of Company Address		25/09/20	101.28KB	Share
NSB	R&D Tax Rebate Received		25/09/20	103.21KB	Share
NSB	Expiry of performance shares		01/09/20	100.42KB	Share
NSB	Appendix 2A Amendment		01/09/20	293.43KB	Share
NSB	Appendix 4E and Annual Report	PRICE SENSITIVE	28/08/20	911.6KB	Share
NSB	Appendix 2A		27/08/20	292.99KB	Share
NSB	Westar Capital Investor Presentation		26/08/20	3.38MB	Share
NSB	Updated Appendix 4C	PRICE SENSITIVE	12/08/20	315.52KB	Share
NSB	Full Report from Multiple Sclerosis Study	PRICE SENSITIVE	04/08/20	349.04KB	Share
NSB	Change in substantial holding		31/07/20	109.13KB	Share
NSB	Appendix 3Y		31/07/20	220.64KB	Share
NSB	Appendix 3Y		31/07/20	216.34KB	Share
NSB	Appendix 3Y		31/07/20	218.17KB	Share
NSB	Appendix 2A		31/07/20	292.57KB	Share
NSB	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/20	302.15KB	Share
NSB	Professor Dao-Yi Yu appointed to Scientific Advisory Board		30/07/20	143.32KB	Share
NSB	Notice of Release from Escrow		20/07/20	100.47KB	Share
NSB	EmtinB Positive Results in MS	PRICE SENSITIVE	14/07/20	203.32KB	Share
NSB	Meet the CEOs Small Cap Webcast		10/06/20	123.9KB	Share
NSB	Techknow Invest Webinar Presentation		20/05/20	2.17MB	Share
NSB	Final Report received for Glaucoma Study	PRICE SENSITIVE	04/05/20	267.07KB	Share
NSB	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/20	710.11KB	Share
NSB	NSB Signs Manufacturing Agreement with Mitsubishi		20/04/20	621.72KB	Share
NSB	Company Secretary Appointment/Resignation		20/04/20	622.58KB	Share
NSB	Positive Results in MS Study	PRICE SENSITIVE	18/03/20	454.02KB	Share
NSB	Trading Halt	PRICE SENSITIVE	16/03/20	429.56KB	Share
NSB	Positive Results in Glaucoma Pig Model	PRICE SENSITIVE	11/03/20	167.4KB	Share
NSB	Trading Halt	PRICE SENSITIVE	09/03/20	113.9KB	Share
NSB	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/20	348.73KB	Share
NSB	NSB - Glaucoma Study Update		03/02/20	153.96KB	Share
NSB	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/20	177.13KB	Share
NSB	Additional US Patent granted	PRICE SENSITIVE	22/01/20	153.53KB	Share
NSB	NSB - Glaucoma Study Update		24/12/19	149.19KB	Share
NSB	Appendix 3B		17/12/19	396.88KB	Share
NSB	Appendix 4G		17/12/19	207.04KB	Share
NSB	CVN Model Indicates Neuroprotective Properties of EmtinB	PRICE SENSITIVE	06/12/19	399.54KB	Share
NSB	NSB - Company Update	PRICE SENSITIVE	02/12/19	172.05KB	Share
NSB	Results of AGM		29/11/19	243.93KB	Share
NSB	AGM Address	PRICE SENSITIVE	29/11/19	1.51MB	Share
NSB	NSB Presentation Nov 2019		19/11/19	2.5MB	Share
NSB	NSB - Company Update		18/11/19	230.04KB	Share
NSB	Appendix 3B - Options Exercised		01/11/19	394.48KB	Share
NSB	Notice of Annual General Meeting/Proxy Form		29/10/19	958.67KB	Share
NSB	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/19	176.85KB	Share

NSB Change of Director's Interest Notice
18/05/21		215.07KB	Share
NSB Update on Pivotal Ocular Safety Studies
05/05/21	PRICE SENSITIVE	618.43KB	Share
NSB Appendix 4C - quarterly
30/04/21	PRICE SENSITIVE	280.13KB	Share
NSB Manufacturing Update
28/04/21	PRICE SENSITIVE	81.69KB	Share
NSB Key Executive Appointments to Support Clinical Studies
31/03/21	PRICE SENSITIVE	109.58KB	Share
NSB Change in substantial holding
11/03/21		201.99KB	Share
NSB Appendix 2A
11/03/21		291.78KB	Share
NSB Strong Investor Support for Exercise of Listed Options
11/03/21		98.29KB	Share
NSB Appendix 2A
08/03/21		287.51KB	Share
NSB Appendix 2A
03/03/21		290.5KB	Share
NSB Change of Director's Interest Notice
03/03/21		214.59KB	Share
NSB Appendix 2A
26/02/21		290.59KB	Share
NSB Change of Director's Interest Notice
26/02/21		218.46KB	Share
NSB Appendix 2A
24/02/21		290.62KB	Share
NSB Half Yearly Report and Accounts
23/02/21	PRICE SENSITIVE	458.12KB	Share
NSB Change of Director's Interest Notice
18/02/21		215.6KB	Share
NSB Appendix 2A
18/02/21		290.56KB	Share
NSB Appendix 2A
16/02/21		290.56KB	Share
NSB Appendix 2A
12/02/21		289.41KB	Share
NSB Change in substantial holding
05/02/21		224.12KB	Share
NSB Appendix 2A
05/02/21		289.22KB	Share
NSB Appendix 2A
29/01/21		290.54KB	Share
NSB Appendix 4C - quarterly
29/01/21	PRICE SENSITIVE	298.77KB	Share
NSB Last Date of Quotation of Listed Options
27/01/21		99.57KB	Share
NSB Expiry of Listed Options
25/01/21		525.54KB	Share
NSB Appendix 2A
22/01/21		290.35KB	Share
NSB Appendix 2A
15/01/21		290.36KB	Share
NSB Appendix 3Y
15/01/21		179.9KB	Share
NSB Appendix 3Y
15/01/21		179.25KB	Share
NSB Appendix 3Y
15/01/21		177.2KB	Share
NSB Appendix 3Y
15/01/21		180.74KB	Share
NSB Appendix 3G
15/01/21		270.37KB	Share
NSB Appendix 2A
08/01/21		290.09KB	Share
NSB Appendix 2A
18/12/20		289.98KB	Share
NSB Results of Meeting
07/12/20		287.96KB	Share
NSB Chairman's Address to Shareholders
07/12/20		1.82MB	Share
NSB Appendix 2A
03/12/20		289.95KB	Share
NSB Corporate Governance Statement
27/11/20		219.98KB	Share
NSB Appendix 4G
25/11/20		256.26KB	Share
NSB NSB to investigate treatment for post-COVID Fibrosis
20/11/20	PRICE SENSITIVE	219.65KB	Share
NSB Trading Halt
19/11/20	PRICE SENSITIVE	264.08KB	Share
NSB Cleansing Notice
16/11/20		121.71KB	Share
NSB Appendix 2A
16/11/20		289.45KB	Share
NSB Completion of Strategic Placement
16/11/20		103.02KB	Share
NSB Cleansing Notice
11/11/20		122.28KB	Share
NSB Terms of Lead Manager Options
11/11/20		114.97KB	Share
NSB Proposed issue of Securities - NSB
11/11/20		28.11KB	Share
NSB Strategic Placement to AlphaSwiss Partners
11/11/20	PRICE SENSITIVE	130.2KB	Share
NSB Trading Halt
09/11/20	PRICE SENSITIVE	601.76KB	Share
NSB Letter to Shareholders - Notice of Meeting/Proxy form
30/10/20		93.38KB	Share
NSB Notice of Annual General Meeting/Proxy Form
30/10/20		988.62KB	Share
NSB Appendix 4C - quarterly
30/10/20	PRICE SENSITIVE	321.92KB	Share
NSB AusBiotech Invest 2020 Conference Presentation
28/10/20		1.86MB	Share
NSB Appendix 2A
13/10/20		282.98KB	Share
NSB BIO Investor Forum Presentation
13/10/20		1.64MB	Share
NSB Appendix 2A
30/09/20		291.46KB	Share
NSB Details of Company Address
25/09/20		101.28KB	Share
NSB R&D Tax Rebate Received
25/09/20		103.21KB	Share
NSB Expiry of performance shares
01/09/20		100.42KB	Share
NSB Appendix 2A Amendment
01/09/20		293.43KB	Share
NSB Appendix 4E and Annual Report
28/08/20	PRICE SENSITIVE	911.6KB	Share
NSB Appendix 2A
27/08/20		292.99KB	Share
NSB Westar Capital Investor Presentation
26/08/20		3.38MB	Share
NSB Updated Appendix 4C
12/08/20	PRICE SENSITIVE	315.52KB	Share
NSB Full Report from Multiple Sclerosis Study
04/08/20	PRICE SENSITIVE	349.04KB	Share
NSB Change in substantial holding
31/07/20		109.13KB	Share
NSB Appendix 3Y
31/07/20		220.64KB	Share
NSB Appendix 3Y
31/07/20		216.34KB	Share
NSB Appendix 3Y
31/07/20		218.17KB	Share
NSB Appendix 2A
31/07/20		292.57KB	Share
NSB Appendix 4C - quarterly
31/07/20	PRICE SENSITIVE	302.15KB	Share
NSB Professor Dao-Yi Yu appointed to Scientific Advisory Board
30/07/20		143.32KB	Share
NSB Notice of Release from Escrow
20/07/20		100.47KB	Share
NSB EmtinB Positive Results in MS
14/07/20	PRICE SENSITIVE	203.32KB	Share
NSB Meet the CEOs Small Cap Webcast
10/06/20		123.9KB	Share
NSB Techknow Invest Webinar Presentation
20/05/20		2.17MB	Share
NSB Final Report received for Glaucoma Study
04/05/20	PRICE SENSITIVE	267.07KB	Share
NSB Appendix 4C - quarterly
30/04/20	PRICE SENSITIVE	710.11KB	Share
NSB NSB Signs Manufacturing Agreement with Mitsubishi
20/04/20		621.72KB	Share
NSB Company Secretary Appointment/Resignation
20/04/20		622.58KB	Share
NSB Positive Results in MS Study
18/03/20	PRICE SENSITIVE	454.02KB	Share
NSB Trading Halt
16/03/20	PRICE SENSITIVE	429.56KB	Share
NSB Positive Results in Glaucoma Pig Model
11/03/20	PRICE SENSITIVE	167.4KB	Share
NSB Trading Halt
09/03/20	PRICE SENSITIVE	113.9KB	Share
NSB Half Yearly Report and Accounts
27/02/20	PRICE SENSITIVE	348.73KB	Share
NSB NSB - Glaucoma Study Update
03/02/20		153.96KB	Share
NSB Appendix 4C - quarterly
31/01/20	PRICE SENSITIVE	177.13KB	Share
NSB Additional US Patent granted
22/01/20	PRICE SENSITIVE	153.53KB	Share
NSB NSB - Glaucoma Study Update
24/12/19		149.19KB	Share
NSB Appendix 3B
17/12/19		396.88KB	Share
NSB Appendix 4G
17/12/19		207.04KB	Share
NSB CVN Model Indicates Neuroprotective Properties of EmtinB
06/12/19	PRICE SENSITIVE	399.54KB	Share
NSB NSB - Company Update
02/12/19	PRICE SENSITIVE	172.05KB	Share
NSB Results of AGM
29/11/19		243.93KB	Share
NSB AGM Address
29/11/19	PRICE SENSITIVE	1.51MB	Share
NSB NSB Presentation Nov 2019
19/11/19		2.5MB	Share
NSB NSB - Company Update
18/11/19		230.04KB	Share
NSB Appendix 3B - Options Exercised
01/11/19		394.48KB	Share
NSB Notice of Annual General Meeting/Proxy Form
29/10/19		958.67KB	Share
NSB Appendix 4C - quarterly
28/10/19	PRICE SENSITIVE	176.85KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.0¢		Change -0.010(5.56%)		Mkt cap ! $56.53M

Open	High	Low	Value	Volume
17.5¢	18.0¢	17.0¢	$15.89K	91.44K

Buyers (Bids)

No.	Vol.	Price($)
2	28363	17.0¢

Sellers (Offers)

Price($)	Vol.	No.
17.5¢	1356	1

View Market Depth

No.	Vol.	Price($)
2	28363	0.170
3	67960	0.165
6	213232	0.160
3	43565	0.155
4	30574	0.150

Price($)	Vol.	No.
0.175	1356	1
0.180	330965	7
0.185	86585	3
0.190	350000	2
0.195	38000	3

Last trade - 12.29pm 18/09/2025 (20 minute delay)


Last 16.5¢		Change -0.010 ( 2.94 %)
Open	High	Low	Volume
17.5¢	17.5¢	16.5¢	130869
Last updated 15.01pm 18/09/2025 ?

NSB (ASX) Chart

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories